High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction–Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation
Authors:
- 22 February 2024
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 56 (3) , 726-728
Abstract
No abstract availableKeywords
Funding Information
- Inha University
This publication has 14 references indexed in Scilit:
- Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplantPediatric Transplantation, 2022
- Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipientsTransplant Infectious Disease, 2020
- IVIG-mediated effector functions in autoimmune and inflammatory diseasesInternational Immunology, 2017
- BK virus infection following kidney transplantationCurrent Opinion in Organ Transplantation, 2014
- Current characteristics and outcome of cytomegalovirus infections after kidney transplantationTransplant Infectious Disease, 2014
- Outcomes of ABO-Incompatible Kidney Transplantation in the United StatesTransplantation, 2012
- Safety of intravenous immunoglobulin (IVIG) therapyAutoimmunity Reviews, 2007
- BK Virus Infection in Transplant Recipients: An Overview and UpdateAmerican Journal of Transplantation, 2006
- ValganciclovirDrugs, 2005
- Impact of Cytomegalovirus Infection on Organ Transplant RecipientsClinical Infectious Diseases, 1990